Back to Search Start Over

Eyelashes hypertrichosis: A benign but frequent adverse effect with cetuximab

Authors :
I. Chabbert
H. Fezoui
L. Cals
X. Tchiknavorian
P. Nouyrigat
N. Maille
Source :
Journal of Clinical Oncology. 23:3747-3747
Publication Year :
2005
Publisher :
American Society of Clinical Oncology (ASCO), 2005.

Abstract

3747 Background: Cetuximab (ERBITUX) is a monoclonal antibody against R-EGF aproved in Europe since 2004 to use in combination with irinotecan in metastatics colorectal cancers resistant to a irino...

Details

ISSN :
15277755 and 0732183X
Volume :
23
Database :
OpenAIRE
Journal :
Journal of Clinical Oncology
Accession number :
edsair.doi...........7973d1b763cf8109a891a49c1d6ba967
Full Text :
https://doi.org/10.1200/jco.2005.23.16_suppl.3747